Back to Search
Start Over
Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study
- Source :
- Leukemia Research Reports, Leukemia research reports, Vol. 2, no.2, p. 64-66 (2013)
- Publisher :
- The Authors. Published by Elsevier Ltd.
-
Abstract
- While in RARS-T, JAK2V617F mutation is common and associated with good prognosis, the clinical and prognostic impact of this mutation in other MDS is unknown. We collected data from 132 non-RARS-T MDS with known JAK2V617F mutation status. JAK2V617F mutation was significantly correlated with lower progression to AML (p
- Subjects :
- Oncology
medicine.medical_specialty
business.industry
Case-control study
Hematology
Bioinformatics
Prognosis
JAK2V617F mutation
Internal medicine
hemic and lymphatic diseases
Mutation (genetic algorithm)
Overall survival
medicine
MDS
Favorable outcome
Good prognosis
Jak2v617f mutation
AML progression
business
Brief Communications
RARS-T
Subjects
Details
- Language :
- English
- ISSN :
- 22130489
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Leukemia Research Reports
- Accession number :
- edsair.doi.dedup.....dbebd296fe2a2fdc5dc9cc37ce1a95fe
- Full Text :
- https://doi.org/10.1016/j.lrr.2013.06.003